HDAC8 may modulate chromatin dynamics and gene expression in melanoma BrM by altering H3K27ac levels and enhancing accessibility at JUN binding sites through the deacetylation of EP300, effectively inactivating it. This evidence concerns the gene JUN and melanoma.